We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medtronic's MDR Reporting Contributed to Warning Letter
Medtronic's MDR Reporting Contributed to Warning Letter
August 2, 2007
The complexity of Medtronic’s procedures for medical device reporting (MDR) and adverse drug experience (ADE) reporting may have contributed to alleged violations cited in a July 3 warning letter, the FDA said.